Willingness of Patients from an Urban Safety-Net Dermatology Clinic to Receive a COVID-19 Vaccine

Main Article Content

Hannah Mumber
Daniela Del Campo
Manuel Alvarado
Jacqueline Watchmaker


COVID-19, vaccination, safety-net, dermatology, survey study, patient attitudes, vaccine hesitancy


Background: While recent vaccine development has initiated a return to pre-COVID "normalcy" both in the dermatology clinic and worldwide, significant challenges remain regarding the public’s willingness to receive a COVID-19 vaccine. Dermatologists often discuss vaccinations with their patients and aid them in making evidence-based medical decisions. Previous studies have looked at the U.S. population’s willingness to receive a COVID-19 vaccine, but no studies have examined the dermatology patient population from an urban, safety-net hospital. Studies have shown that understanding the target audience is the first step towards increasing vaccine acceptance.

Methods: A cross-sectional, telephone-based survey study was administered to 326 patients of an urban, safety-net hospital from July 2020 to August 2020 in order to assess willingness to obtain a COVID-19 vaccine.

Results: Our survey study showed that 57.7% of patients with a recent dermatology appointment are willing to receive a COVID-19 vaccine and that safety concerns represent the main reason for patient hesitancy. Patients who do not regularly receive a flu vaccine, non-Caucasian patients, and those who know someone who tested positive for COVID-19 are less willing to receive a COVID-19 vaccine. Patients with a recent dermatology appointment are more willing to receive a COVID-19 vaccine than those who did not have a recent dermatology appointment.

Conclusions: Our results provide dermatologists, especially those working in urban safety-net clinics, with key information about the attitude of patients toward the COVID-19 vaccine.


1 Baden, L.R. et al. (2021) Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403–41

2 Polack, F.P. et al. (2020) Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 383, 2603–2615

3 Sadoff, J. et al. (2021) Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N. Engl. J. Med. 384, 1824–1835

4 Reiter, P.L. et al. (2020) Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 38, 6500–6507

5 Daly, M. and Robinson, E. (2020) Willingness to vaccinate against COVID-19 in the US: Longitudinal evidence from a nationally representative sample of adults from April-October 2020. medRxiv DOI: 10.1101/2020.11.27.20239970

6 Schaffer DeRoo, S. et al. (2020) Planning for a COVID-19 Vaccination Program. JAMA 323, 2458–2459

7 Volpp, K.G. and Cannuscio, C.C. (2021) Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake. N. Engl. J. Med. 385, e1

8 Pawelec, G. and Picard, E. (2021) Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants. Signal Transduct. Target. Ther. 6, 259

9 Wang, C. et al. (2021) SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group. Australas. J. Dermatol. 62, 151–156

10 Lazarus, J.V. et al. (2021) A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 27, 225–228

11 Attwell, K. and Smith, D.T. (2018) Hearts, minds, nudges and shoves: (How) can we mobilise communities for vaccination in a marketised society? Vaccine 36, 6506–6508

12 Thomson, A. et al. (2018) Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions. Vaccine 36, 6457–6458

13 Xia, T. et al. (2019) Understanding flu vaccination acceptance among U.S. adults: the health belief model and media sources. ICRCC 2, 35–37

14 CDC COVID Data Tracker. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total. Accessed September 6, 2021.

15 Al-Amer, R. et al. (2021) COVID-19 vaccination intention in the first year of the pandemic: A systematic review. J. Clin. Nurs. DOI: 10.1111/jocn.15951

16 Dror, A.A. et al. (2020) Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol 35, 775–779

17 Ezeonwu, M.C. (2018) Specialty-care access for community health clinic patients: processes and barriers. J Multidiscip Healthc 11, 109–119

18 Biasio, L.R. (2017) Vaccine hesitancy and health literacy. Hum. Vaccin. Immunother. 13, 701–702

19 COVID-19 vaccine information. https://www.aad.org/member/practice/coronavirus/vaccines. Accessed August 30, 2021.

20 Butt AA, Nafady-Hego H, Chemaitelly H, et al. Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination: Breakthrough SARS-CoV-2 infection. Int J Infect Dis. August 2021. doi:10.1016/j.ijid.2021.08.008